The global Semi-solid Dosage market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Semi-solid Dosage is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Semi-solid Dosage include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG and GlaxoSmithKline plc, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Semi-solid Dosage, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Semi-solid Dosage, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Semi-solid Dosage, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Semi-solid Dosage sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Semi-solid Dosage market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Semi-solid Dosage sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
SigmaAldrich
Segment by Type
Ointment
Paste
Plaster
Gel
Segment by Application
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Semi-solid Dosage in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Semi-solid Dosage manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Semi-solid Dosage sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Semi-solid Dosage Product Introduction
1.2 Market by Type
1.2.1 Global Semi-solid Dosage Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ointment
1.2.3 Paste
1.2.4 Plaster
1.2.5 Gel
1.3 Market by Application
1.3.1 Global Semi-solid Dosage Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.2 Global Semi-solid Dosage Revenue by Region
2.2.1 Global Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Semi-solid Dosage Revenue by Region (2019-2024)
2.2.3 Global Semi-solid Dosage Revenue by Region (2025-2030)
2.2.4 Global Semi-solid Dosage Revenue Market Share by Region (2019-2030)
2.3 Global Semi-solid Dosage Sales Estimates and Forecasts 2019-2030
2.4 Global Semi-solid Dosage Sales by Region
2.4.1 Global Semi-solid Dosage Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Semi-solid Dosage Sales by Region (2019-2024)
2.4.3 Global Semi-solid Dosage Sales by Region (2025-2030)
2.4.4 Global Semi-solid Dosage Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Semi-solid Dosage Sales by Manufacturers
3.1.1 Global Semi-solid Dosage Sales by Manufacturers (2019-2024)
3.1.2 Global Semi-solid Dosage Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Semi-solid Dosage in 2023
3.2 Global Semi-solid Dosage Revenue by Manufacturers
3.2.1 Global Semi-solid Dosage Revenue by Manufacturers (2019-2024)
3.2.2 Global Semi-solid Dosage Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Semi-solid Dosage Revenue in 2023
3.3 Global Key Players of Semi-solid Dosage, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Semi-solid Dosage Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Semi-solid Dosage, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Semi-solid Dosage, Product Offered and Application
3.8 Global Key Manufacturers of Semi-solid Dosage, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Semi-solid Dosage Sales by Type
4.1.1 Global Semi-solid Dosage Historical Sales by Type (2019-2024)
4.1.2 Global Semi-solid Dosage Forecasted Sales by Type (2025-2030)
4.1.3 Global Semi-solid Dosage Sales Market Share by Type (2019-2030)
4.2 Global Semi-solid Dosage Revenue by Type
4.2.1 Global Semi-solid Dosage Historical Revenue by Type (2019-2024)
4.2.2 Global Semi-solid Dosage Forecasted Revenue by Type (2025-2030)
4.2.3 Global Semi-solid Dosage Revenue Market Share by Type (2019-2030)
4.3 Global Semi-solid Dosage Price by Type
4.3.1 Global Semi-solid Dosage Price by Type (2019-2024)
4.3.2 Global Semi-solid Dosage Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Semi-solid Dosage Sales by Application
5.1.1 Global Semi-solid Dosage Historical Sales by Application (2019-2024)
5.1.2 Global Semi-solid Dosage Forecasted Sales by Application (2025-2030)
5.1.3 Global Semi-solid Dosage Sales Market Share by Application (2019-2030)
5.2 Global Semi-solid Dosage Revenue by Application
5.2.1 Global Semi-solid Dosage Historical Revenue by Application (2019-2024)
5.2.2 Global Semi-solid Dosage Forecasted Revenue by Application (2025-2030)
5.2.3 Global Semi-solid Dosage Revenue Market Share by Application (2019-2030)
5.3 Global Semi-solid Dosage Price by Application
5.3.1 Global Semi-solid Dosage Price by Application (2019-2024)
5.3.2 Global Semi-solid Dosage Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Semi-solid Dosage Market Size by Type
6.1.1 US & Canada Semi-solid Dosage Sales by Type (2019-2030)
6.1.2 US & Canada Semi-solid Dosage Revenue by Type (2019-2030)
6.2 US & Canada Semi-solid Dosage Market Size by Application
6.2.1 US & Canada Semi-solid Dosage Sales by Application (2019-2030)
6.2.2 US & Canada Semi-solid Dosage Revenue by Application (2019-2030)
6.3 US & Canada Semi-solid Dosage Market Size by Country
6.3.1 US & Canada Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Semi-solid Dosage Sales by Country (2019-2030)
6.3.3 US & Canada Semi-solid Dosage Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Semi-solid Dosage Market Size by Type
7.1.1 Europe Semi-solid Dosage Sales by Type (2019-2030)
7.1.2 Europe Semi-solid Dosage Revenue by Type (2019-2030)
7.2 Europe Semi-solid Dosage Market Size by Application
7.2.1 Europe Semi-solid Dosage Sales by Application (2019-2030)
7.2.2 Europe Semi-solid Dosage Revenue by Application (2019-2030)
7.3 Europe Semi-solid Dosage Market Size by Country
7.3.1 Europe Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Semi-solid Dosage Sales by Country (2019-2030)
7.3.3 Europe Semi-solid Dosage Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Semi-solid Dosage Market Size
8.1.1 China Semi-solid Dosage Sales (2019-2030)
8.1.2 China Semi-solid Dosage Revenue (2019-2030)
8.2 China Semi-solid Dosage Market Size by Application
8.2.1 China Semi-solid Dosage Sales by Application (2019-2030)
8.2.2 China Semi-solid Dosage Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Semi-solid Dosage Market Size by Type
9.1.1 Asia Semi-solid Dosage Sales by Type (2019-2030)
9.1.2 Asia Semi-solid Dosage Revenue by Type (2019-2030)
9.2 Asia Semi-solid Dosage Market Size by Application
9.2.1 Asia Semi-solid Dosage Sales by Application (2019-2030)
9.2.2 Asia Semi-solid Dosage Revenue by Application (2019-2030)
9.3 Asia Semi-solid Dosage Sales by Region
9.3.1 Asia Semi-solid Dosage Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Semi-solid Dosage Revenue by Region (2019-2030)
9.3.3 Asia Semi-solid Dosage Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Type
10.1.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Semi-solid Dosage Market Size by Application
10.2.1 Middle East, Africa and Latin America Semi-solid Dosage Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country
10.3.1 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Semi-solid Dosage Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Semi-solid Dosage Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Johnson & Johnson Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Overview
11.2.3 Merck & Co Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck & Co Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Hisamitsu Pharmaceutical
11.4.1 Hisamitsu Pharmaceutical Company Information
11.4.2 Hisamitsu Pharmaceutical Overview
11.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hisamitsu Pharmaceutical Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Company Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glenmark Pharmaceuticals Recent Developments
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Information
11.6.2 Cipla Ltd Overview
11.6.3 Cipla Ltd Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Cipla Ltd Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Ltd Recent Developments
11.7 Nestle SA
11.7.1 Nestle SA Company Information
11.7.2 Nestle SA Overview
11.7.3 Nestle SA Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Nestle SA Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nestle SA Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Overview
11.8.3 Novartis AG Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis AG Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis AG Recent Developments
11.9 GlaxoSmithKline plc
11.9.1 GlaxoSmithKline plc Company Information
11.9.2 GlaxoSmithKline plc Overview
11.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 GlaxoSmithKline plc Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline plc Recent Developments
11.10 Bausch Health Companies
11.10.1 Bausch Health Companies Company Information
11.10.2 Bausch Health Companies Overview
11.10.3 Bausch Health Companies Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bausch Health Companies Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bausch Health Companies Recent Developments
11.11 Allergan
11.11.1 Allergan Company Information
11.11.2 Allergan Overview
11.11.3 Allergan Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Allergan Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Allergan Recent Developments
11.12 Biofrontera
11.12.1 Biofrontera Company Information
11.12.2 Biofrontera Overview
11.12.3 Biofrontera Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Biofrontera Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biofrontera Recent Developments
11.13 Crown Laboratories
11.13.1 Crown Laboratories Company Information
11.13.2 Crown Laboratories Overview
11.13.3 Crown Laboratories Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Crown Laboratories Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Crown Laboratories Recent Developments
11.14 Akorn
11.14.1 Akorn Company Information
11.14.2 Akorn Overview
11.14.3 Akorn Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Akorn Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Akorn Recent Developments
11.15 Ingenus Pharmaceuticals
11.15.1 Ingenus Pharmaceuticals Company Information
11.15.2 Ingenus Pharmaceuticals Overview
11.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ingenus Pharmaceuticals Recent Developments
11.16 Sun Pharmaceuticals
11.16.1 Sun Pharmaceuticals Company Information
11.16.2 Sun Pharmaceuticals Overview
11.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Sun Pharmaceuticals Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sun Pharmaceuticals Recent Developments
11.17 Crescita Therapeutics
11.17.1 Crescita Therapeutics Company Information
11.17.2 Crescita Therapeutics Overview
11.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Crescita Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Crescita Therapeutics Recent Developments
11.18 Mylan N.V.
11.18.1 Mylan N.V. Company Information
11.18.2 Mylan N.V. Overview
11.18.3 Mylan N.V. Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Mylan N.V. Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Mylan N.V. Recent Developments
11.19 Encore Dermatology
11.19.1 Encore Dermatology Company Information
11.19.2 Encore Dermatology Overview
11.19.3 Encore Dermatology Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Encore Dermatology Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Encore Dermatology Recent Developments
11.20 LEO Pharma
11.20.1 LEO Pharma Company Information
11.20.2 LEO Pharma Overview
11.20.3 LEO Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 LEO Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 LEO Pharma Recent Developments
11.21 Almirall, S.A
11.21.1 Almirall, S.A Company Information
11.21.2 Almirall, S.A Overview
11.21.3 Almirall, S.A Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Almirall, S.A Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Almirall, S.A Recent Developments
11.22 Aclaris Therapeutics
11.22.1 Aclaris Therapeutics Company Information
11.22.2 Aclaris Therapeutics Overview
11.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Aclaris Therapeutics Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Aclaris Therapeutics Recent Developments
11.23 Taro Pharmaceutical Industries
11.23.1 Taro Pharmaceutical Industries Company Information
11.23.2 Taro Pharmaceutical Industries Overview
11.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Taro Pharmaceutical Industries Recent Developments
11.24 Teligent Pharma
11.24.1 Teligent Pharma Company Information
11.24.2 Teligent Pharma Overview
11.24.3 Teligent Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.24.4 Teligent Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Teligent Pharma Recent Developments
11.25 Perrigo Pharma
11.25.1 Perrigo Pharma Company Information
11.25.2 Perrigo Pharma Overview
11.25.3 Perrigo Pharma Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.25.4 Perrigo Pharma Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Perrigo Pharma Recent Developments
11.26 SigmaAldrich
11.26.1 SigmaAldrich Company Information
11.26.2 SigmaAldrich Overview
11.26.3 SigmaAldrich Semi-solid Dosage Sales, Price, Revenue and Gross Margin (2019-2024)
11.26.4 SigmaAldrich Semi-solid Dosage Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 SigmaAldrich Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Semi-solid Dosage Industry Chain Analysis
12.2 Semi-solid Dosage Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Semi-solid Dosage Production Mode & Process
12.4 Semi-solid Dosage Sales and Marketing
12.4.1 Semi-solid Dosage Sales Channels
12.4.2 Semi-solid Dosage Distributors
12.5 Semi-solid Dosage Customers
13 Market Dynamics
13.1 Semi-solid Dosage Industry Trends
13.2 Semi-solid Dosage Market Drivers
13.3 Semi-solid Dosage Market Challenges
13.4 Semi-solid Dosage Market Restraints
14 Key Findings in The Global Semi-solid Dosage Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
SigmaAldrich
听
听
*If Applicable.